BXRXQ — Baudax Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Baudax Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	—	17.7	30.3	15.9	5.26
Net Total Accounts Receivable
Net Total Receivables	—	—	0.051	0.542	0.335
Total Inventory
Prepaid Expenses
Total Current Assets	2.51	20.1	36.7	23.5	6.35
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.98	5.55	5.63	5.98	1.56
Net Goodwill
Net Intangible Assets
Total Assets	35	54.2	68.7	53.3	10
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22.8	7.71	18.1	15.6	21.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	103	70.9	83.5	40.1	34.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-68.3	-16.7	-14.8	13.2	-24.2
Total Liabilities & Shareholders' Equity	35	54.2	68.7	53.3	10
Total Common Shares Outstanding
Total Preferred Shares Outstanding